{{Rsnum
|rsid=10876864
|Gene=SUOX
|Chromosome=12
|position=56007301
|Orientation=plus
|GMAF=0.4518
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IKZF4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 36.3 | 46.9 | 16.8
| HCB | 57.7 | 35.8 | 6.6
| JPT | 57.5 | 40.7 | 1.8
| YRI | 2.7 | 22.6 | 74.7
| ASW | 7.0 | 38.6 | 54.4
| CHB | 57.7 | 35.8 | 6.6
| CHD | 59.6 | 33.9 | 6.4
| GIH | 59.4 | 31.7 | 8.9
| LWK | 3.6 | 28.2 | 68.2
| MEX | 55.2 | 36.2 | 8.6
| MKK | 17.3 | 50.6 | 32.1
| TSI | 37.6 | 51.5 | 10.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22951725
  |Trait=Vitiligo
  |Title=Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population.
  |RiskAllele=G
  |Pval=8E-12
  |OR=1.18
  |ORtxt=[1.13-1.24]
  }}

{{PMID Auto
|PMID=18840781
|Title=Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=19956108
|Title=Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1.
|OA=1
}}

{{PMID Auto
|PMID=19966804
|Title=Geographical genomics of human leukocyte gene expression variation in southern Morocco.
|OA=1
}}

{{PMID Auto
|PMID=20668683
|Title=Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk.
|OA=1
}}

{{PMID Auto
|PMID=21559886
|Title=Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}